Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Reexamination Certificate
2006-04-12
2011-11-08
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
Reexamination Certificate
active
08053470
ABSTRACT:
The invention discloses a process for preparing a polynuclear ferric hydroxide-saccharide complex, including: adding an aqueous solution of an alkaline substance drop-wise into an aqueous solution of iron salt at a temperature of 5-20° C. until pH 6-8, collecting the polynuclear ferric hydroxide from the reaction mixture by a conventional method; reacting the polynuclear ferric hydroxide with a saccharide in a solution of an alkaline substance for 10-40 hours at 106-125° C. under pH 10-12, resulting in a crude product having an isoelectric point of 4.4-5.3 and a weight average molecular weight of 20,000-100,000 Daltons, and then harvesting the polynuclear ferric hydroxide-saccharide complex from the crude product. The process can precisely control the molecular weight of the polynuclear ferric hydroxide-saccharide complex without an effect on the other characteristics of the product, for example its saccharide content or isoelectric point etc. Furthermore, it is very simple and readily applicable in industry.
REFERENCES:
patent: 3686397 (1972-08-01), Muller
patent: 3794722 (1974-02-01), Taya
patent: 6537820 (2003-03-01), Beck et al.
patent: 2003/0216566 (2003-11-01), Kumari et al.
patent: 1097989 (1995-02-01), None
patent: 3844065 (1990-07-01), None
patent: 1 756 132 (2007-02-01), None
patent: 187116 (2000-01-01), None
patent: 187116 (2002-02-01), None
patent: 2198665 CI (2003-02-01), None
patent: 2005/000210 (2005-01-01), None
patent: 2005/094202 (2005-10-01), None
patent: 2005/116040 (2005-12-01), None
patent: 2006/006185 (2006-01-01), None
Nissim et al, The Lancet, 1949, 23, 686-89.
USP “Iron Sucrose Injection” United States Pharmacopeia and National Formulary (USP27-NF22) 2004, pp. 1025-1029.
National Kidney Foundation K/DOQI Guidelines, KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease, pp. 1-21, 2006.
Venofer, pp. 1-9, 1997.
Geisser, et al., “Structure / Histotoxicity Relationship of Parental Iron Preparations,” Arzneim.-Forsch./Drug Res., 42 (II), No. 12, (1992), pp. 1439-1452.
Iron Sucrose Injection, pp. 5, 2008.
Nissim, et al., “Preparation and Standardisation of Saccharated Iron Oxide for Intravenous Administration,” The Lancet, Apr. 23, 1949, pp. 686-689.
Deng Jie
Feng Jinhua
Xiao Bo
Xiao Jinmai
Chongqing Pharmaceutical Research Institute Co., Ltd.
Jiang Shaojia Anna
Krishnan Ganapathy
Workman Nydegger
LandOfFree
Process for the preparation of polynuclear ferric... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of polynuclear ferric..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of polynuclear ferric... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4262388